BMO Capital Markets Increases Quebecor (TSE:QBR.B) Price Target to C$42.00
Quebecor (TSE:QBR.B – Free Report) had its price target raised by BMO Capital Markets from C$39.00 to C$42.00 in a report released on Monday, BayStreet.CA...
Finning International (TSE:FTT) Price Target Lowered to C$48.00 at BMO Capital Markets
Finning International (TSE:FTT – Free Report) had its target price decreased by BMO Capital Markets from C$52.00 to C$48.00 in a research note issued to...
Humacyte (NASDAQ:HUMA) Receives New Coverage from Analysts at HC Wainwright
HC Wainwright assumed coverage on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report issued on Monday morning, MarketBeat reports. The brokerage issued a...
CRISPR Therapeutics (NASDAQ:CRSP) PT Raised to $88.00
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its price objective increased by Needham & Company LLC from $85.00 to $88.00 in a research note issued...
HC Wainwright Reaffirms Buy Rating for Blueprint Medicines (NASDAQ:BPMC)
HC Wainwright reiterated their buy rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a report released on Monday, Benzinga reports. HC Wainwright...
Saga Communications (NASDAQ:SGA) Downgraded by StockNews.com
StockNews.com downgraded shares of Saga Communications (NASDAQ:SGA – Free Report) from a buy rating to a hold rating in a research note published on Tuesday....